Oxytocin in the medial prefrontal cortex attenuates anxiety: Anatomical and receptor specificity and mechanism of action
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Numerous studies in animals and humans have established that oxytocin (OT) reduces anxiety. In rats, the prelimbic (PL) subregion of the medial prefrontal cortex (mPFC) is among the brain areas implicated in the anxiolytic actions of OT. However, questions remain about the anatomical and receptor specificity of OT and its mechanism of action. Here we assessed whether the regulation of anxiety by mPFC OT is restricted to the PL subregion and evaluated whether oxytocin receptor (OTR) activation is required for OT to have an anxiolytic effect. We also examined whether OT interacts with GABA in the mPFC to reduce anxiety and investigated the extent to which OT in the mPFC affects activation of mPFC GABA neurons as well as neuronal activation in the amygdala, a primary target of the mPFC which is part of the neural network regulating anxiety. We found that OT reduced anxiety-like behavior when delivered to the PL, but not infralimbic or anterior cingulate subregions of the mPFC. The anxiolytic effect of OT in the PL mPFC was blocked by pretreatment with an OTR, but not a vasopressin receptor antagonist as well as with a GABAA receptor antagonist. Lastly, administration of OT to the PL mPFC was accompanied by increased activation of GABA neurons in the PL mPFC and altered neuronal activation of the amygdala following anxiety testing. These results demonstrate that OT in the PL mPFC attenuates anxiety-related behavior and may do so by engaging GABAergic neurons which ultimately modulate downstream brain regions implicated in anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · cited 4×
“The anxiolytic effect of OT in rodents translates to humans with several studies demonstrating that intranasal administration of OT suppresses anxiety responses in healthy individuals as well as patients with anxiety disorders (de Oliveira et al., 2012; Feifel et al., 2011; Guastella et al., 2009; Heinrichs et al., 20…”
BackgroundInfluentialOxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 4×
“The anxiolytic effect of OT in the PL mPFC in both tests suggests that anxiety in non-social and social contexts is sensitive to PL OT although for the SI test, it is difficult to attribute the increased social interaction time to diminished anxiety alone since OT administration is also widely known to promote prosoci…”
BackgroundInfluentialSocial effects of oxytocin in humans: context and person matter
Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.05.002 · Cited by 1,581 · cited 1×
“It is also important to consider emerging evidence that OT is not solely involved in reducing fear and anxiety but can also have the opposite action and can increase fear and anxiety (Bartz et al., 2011; Grillon et al., 2013; Guzman et al., 2013; Lahoud and Maroun, 2013; Toth et al., 2012).”
BackgroundDifferential projections of the infralimbic and prelimbic cortex in the rat
Vertes, R. P. (2004) · Synapse · doi:10.1002/syn.10279 · Cited by 1,550 · cited 4×
“The BLA is the main target of glutamatergic projections from the PL mPFC (Gabbott et al., 2005; Vertes, 2004) and increased activation of the BLA is associated with heightened anxiety (Hale et al., 2006; Tye et al., 2011; Wang et al., 2011).”
BackgroundInfluentialAnatomical analysis of afferent projections to the medial prefrontal cortex in the rat
Hoover, W. B., & Vertes, R. P. (2007) · Brain Structure and Function · doi:10.1007/s00429-007-0150-4 · Cited by 1,365 · cited 1×
“…of connectivity with subcortical and cortical structures which are known to regulate the expression of anxiety-like behavior (Calhoon and Tye, 2015; Hoover and Vertes, 2007; Likhtik et al., 2005; Myers-Schulz and Koenigs, 2012; Vertes, 2004) and as such have been shown in some studies to…”
BackgroundPrefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers
Gabbott, P. L. A., Warner, T. A., Jays, P. R. L., Salway, P., & Busby, S. J. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20738 · Cited by 1,227 · cited 6×
“…dorsally located PL region having an excitatory influence through its glutamatergic projections to downstream limbic regions including the amygdala (Adhikari, 2014; Berretta et al., 2005; Brinley-Reed et al., 1995; Gabbott et al., 2005; Leuner and Shors, 2013; McDonald et al., 1996; Vertes, 2004).”
BackgroundInfluentialSierra-Mercado, D., Padilla-Coreano, N., & Quirk, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.184 · Cited by 1,190 · cited 2×
“…1 µg nor the 0.1 µg dose of OT was effective, even though both regions have also been implicated in fear and anxiety regulation (Cg1: Bissiere et al., 2008; Albrechet-Souza et al., 2009; but see Bissiere et al., 2006; IL: Vidal-Gonzalez et al., 2006; Sierra-Mercado et al., 2011; Bi et al., 2013).”
BackgroundInfluentialEvoked axonal oxytocin release in the central amygdala attenuates fear response
Knobloch, H. S., Charlet, A., Hoffmann, L. C., Eliava, M., Khrulev, S., Cetin, A. H., Osten, P., Schwarz, M. K., Seeburg, P. H., Stoop, R., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.030 · Cited by 1,049 · cited 4×
“Interestingly, GABA has also been previously shown to mediate the anxiolytic action of OT within the amygdala (Huber et al., 2005; Knobloch et al., 2012) and PVN (Smith et al., 2016) suggesting a similar mechanism across these brain regions.”
BackgroundInfluentialVasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala
Huber, D., Veinante, P., & Stoop, R. (2005) · Science · doi:10.1126/science.1105636 · Cited by 804 · cited 2×
“Interestingly, GABA has also been previously shown to mediate the anxiolytic action of OT within the amygdala (Huber et al., 2005; Knobloch et al., 2012) and PVN (Smith et al.”
BackgroundResolving the neural circuits of anxiety
Calhoon, G. G., & Tye, K. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4101 · Cited by 766 · cited 4×
“Without examining the phenotype of the activated cells or differentiating among the different subregions within the CEA (medial vs lateral CeA), which can have opposing influences on anxiety (Calhoon and Tye, 2015; Ressler, 2010), it is difficult to make any further conclusions.”
BackgroundInfluentialOxytocin enables maternal behaviour by balancing cortical inhibition
Marlin, B. J., Mitre, M., D’amour, J. A., Chao, M. V., & Froemke, R. C. (2015) · Nature · doi:10.1038/nature14402 · Cited by 744
Vidal-Gonzalez, I., Vidal-Gonzalez, B., Rauch, S. L., & Quirk, G. J. (2006) · Learning & Memory · doi:10.1101/lm.306106 · Cited by 705 · cited 1×
“…1 µg nor the 0.1 µg dose of OT was effective, even though both regions have also been implicated in fear and anxiety regulation (Cg1: Bissiere et al., 2008; Albrechet-Souza et al., 2009; but see Bissiere et al., 2006; IL: Vidal-Gonzalez et al., 2006; Sierra-Mercado et al., 2011; Bi et al., 2013).”
BackgroundInfluentialPrefrontal involvement in the regulation of emotion: convergence of rat and human studies
Quirk, G. J., & Beer, J. S. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.07.004 · Cited by 701 · cited 1×
“While the mPFC is often regarded as having an inhibitory influence on fear and anxiety, numerous studies suggest that it can also stimulate fear and anxiety (Calhoon and Tye, 2015; Quirk and Beer, 2006).”
BackgroundMcDonald, A. J., Mascagni, F., & Guo, L. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00417-3 · Cited by 689 · cited 4×
“Of particular interest are the basolateral (BLA) and central (CEA) amygdala, two components of the neural network regulating anxiety that receive direct and indirect input from the mPFC (Adhikari, 2014; Berretta et al., 2005; Brinley-Reed et al., 1995; Gabbott et al., 2005; Leuner and Shors, 2013; McDonald et al., 199…”
BackgroundInfluentialNeuropeptidergic regulation of affiliative behavior and social bonding in animals
Lim, M. M., & Young, L. J. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.028 · Cited by 624
Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L. J., Onaka, T., & Nishimori, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5593-08.2009 · Cited by 608 · cited 2×
“, 2001; Neumann, 2002), raphe nucleus (Yoshida et al., 2009), and most recently, the prelimbic (PL) region of the medial prefrontal cortex (mPFC) (Sabihi et al.”
BackgroundCho, M. M., DeVries, A. C., Williams, J. R., & Carter, C. S. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.5.1071 · Cited by 529
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520
Oxytocin in general anxiety and social fear: a translational approach
Neumann, I. D., & Slattery, D. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.004 · Cited by 468
Bale, T. L., Davis, A. M., Auger, A. P., Dorsa, D. M., & McCarthy, M. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02546.2001 · Cited by 446 · cited 12×
“Although 1 μg OT is a relatively high dose, this dose was also shown to be anxiolytic in the amygdala (Bale et al., 2001).”
BackgroundMethodResultInfluentialOxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · cited 4×
“Manning) is highly specific to the V1a receptor and is devoid of any anti-OT activity in vivo, thus allowing for the discrimination between V1a and OT receptors (Manning et al., 2012).”
BackgroundMethodInfluentialLukas, M., Toth, I., Reber, S. O., Slattery, D. A., Veenema, A. H., & Neumann, I. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.95 · Cited by 403 · cited 6×
“EPM, OF, light-dark box) that have shown an anxiolytic effect of endogenous brain OT only during periods of high OT system activity such as the postpartum period (Lukas et al., 2011; Neumann, 2002; Neumann et al., 2000; Sabihi et al., 2014a; Slattery and Neumann, 2010).”
BackgroundMethodResultInfluentialBosch, O. J., & Neumann, I. D. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.11.002 · Cited by 400
Vasopressin and oxytocin receptors in the central nervous system
Tribollet, E., & Barberis, C. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.60 · Cited by 399 · cited 2×
“, 1999) since OTR and AVPR antagonists have been shown to be approximately 10–100 times more effective in receptor binding than the natural ligands (Barberis and Tribollet, 1996).”
BackgroundNeumann, I. D. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39014-9 · Cited by 387
Sala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.022 · Cited by 375 · cited 6×
“1 μg) followed 10 min later (Sala et al., 2011; Yosten and Samson, 2010) by an infusion of saline or OT (1 μg) resulting in the following six groups: saline+saline (n = 7), saline+OT (n = 7), OTR-A+saline (n = 5), OTRA+OT (n = 7), AVPR-A+saline (n = 5), AVPR-A+OT (n = 7).”
BackgroundMethodInfluentialGuastella, A. J., Howard, A. L., Dadds, M. R., Mitchell, P., & Carson, D. S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.01.005 · Cited by 366
Prefrontal Control of the Amygdala
Likhtik, E., Pelletier, J. G., Paz, R., & Paré, D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2314-05.2005 · Cited by 361
Central vasopressin and oxytocin release: regulation of complex social behaviours
VEENEMA, A., & NEUMANN, I. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00422-6 · Cited by 338 · cited 1×
“…interest None of the authors have financial interests or potential conflicts of interest to report. uthor M anuscript A uthor M anuscript A uthor M anuscript implicated in the regulation of anxiety (Benarroch, 2013; MacDonald and Feifel, 2014; Neumann and Landgraf, 2012; Veenema and Neumann, 2008).”
BackgroundAmygdala activity, fear, and anxiety: modulation by stress.
Ressler, K. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.027 · Cited by 337 · cited 1×
“Without examining the phenotype of the activated cells or differentiating among the different subregions within the CEA (medial vs lateral CeA), which can have opposing influences on anxiety (Calhoon and Tye, 2015; Ressler, 2010), it is difficult to make any further conclusions.”
BackgroundFunctional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders
Myers-Schulz, B., & Koenigs, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.88 · Cited by 333 · cited 2×
“The various subregions of the mPFC show different patterns of connectivity with subcortical and cortical structures which are known to regulate the expression of anxiety-like behavior (Calhoon and Tye, 2015; Hoover and Vertes, 2007; Likhtik et al., 2005; Myers-Schulz and Koenigs, 2012; Vertes, 2004) and as such have b…”
BackgroundRing, R. H., Malberg, J. E., Potestio, L., Ping, J., Boikess, S., Luo, B., Schechter, L. E., Rizzo, S., Rahman, Z., & Rosenzweig-Lipson, S. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0293-z · Cited by 319 · cited 2×
“…to attenuate anxiety-like behavior when administered peripherally or centrally (Ayers et al., 2011; Bale et al., 2001; Blume et al., 2008; Mak et al., 2012; McCarthy et al., 1996; Ring et al., 2006; Sabihi et al., 2014b; Slattery and Neumann, 2010; Uvnas-Moberg et al., 1994; Windle et al., 1997).”
BackgroundA distributed network for social cognition enriched for oxytocin receptors
Mitre, M., Marlin, B. J., Schiavo, J. K., Morina, E., Norden, S. E., Hackett, T. A., Aoki, C. J., Chao, M. V., & Froemke, R. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2409-15.2016 · Cited by 305 · cited 3×
“OTR are located in the mPFC (Duchemin et al., 2017; Gould and Zingg, 2003; Insel and Shapiro, 1992; Liu et al., 2005; Mak et al., 2012; Mitre et al., 2016; Nakajima et al., 2014; Smeltzer et al., 2006) although little is known about subregional differences in OTR density which may be another factor…”
BackgroundMANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Stress, anxiety, and dendritic spines: What are the connections?
Leuner, B., & Shors, T. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.021 · Cited by 284 · cited 2×
“…(BLA) and central (CEA) amygdala, two components of the neural network regulating anxiety that receive direct and indirect input from the mPFC (Adhikari, 2014; Berretta et al., 2005; Brinley-Reed et al., 1995; Gabbott et al., 2005; Leuner and Shors, 2013; McDonald et al., 1996; Vertes, 2004).”
BackgroundSelf-citationKnapska, E., & Maren, S. (2009) · Learning & Memory · doi:10.1101/lm.1463909 · Cited by 264 · cited 1×
“Rats were euthanized and brains removed ~70 min after anxiety testing consistent with previous studies and peak c-Fos expression (Bossert et al., 2011; Knapska and Maren, 2009; Rey et al., 2014).”
MethodNakajima, M., Görlich, A., & Heintz, N. (2014) · Cell · doi:10.1016/j.cell.2014.09.020 · Cited by 262 · cited 7×
“Although it also possible that OT may directly influence glutamatergic neurotransmission in the mPFC to affect anxiety (Ninan, 2011; Qi et al., 2012; Qi et al., 2009), this seems unlikely as all studies to date have only found OTR on GABAergic interneurons (Nakajima et al., 2014).”
BackgroundInfluentialInfralimbic cortex activation increases c-fos expression in intercalated neurons of the amygdala
Berretta, S., Pantazopoulos, H., Caldera, M., Pantazopoulos, P., & Paré, D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.020 · Cited by 223 · cited 4×
“Of particular interest are the basolateral (BLA) and central (CEA) amygdala, two components of the neural network regulating anxiety that receive direct and indirect input from the mPFC (Adhikari, 2014; Berretta et al., 2005; Brinley-Reed et al., 1995; Gabbott et al., 2005; Leuner and Shors, 2013; McDonald et al., 199…”
BackgroundInfluentialSmeltzer, M. D., Curtis, J. T., Aragona, B. J., & Wang, Z. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.019 · Cited by 222 · cited 4×
“…et al., 2017; Gould and Zingg, 2003; Insel and Shapiro, 1992; Liu et al., 2005; Mak et al., 2012; Mitre et al., 2016; Nakajima et al., 2014; Smeltzer et al., 2006) although little is known about subregional differences in OTR density which may be another factor contributing to the observed…”
BackgroundInfluentialBoth oxytocin and vasopressin may influence alloparental behavior in male prairie voles
Bales, K. L., Kim, A. J., Lewis-Reese, A. D., & Sue Carter, C. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.01.004 · Cited by 217 · cited 1×
“This dose was lower than that of the peptide (Bales et al., 2004; Cho et al., 1999) since OTR and AVPR antagonists have been shown to be approximately 10–100 times more effective in receptor binding than the natural ligands (Barberis and Tribollet, 1996).”
BackgroundFear-enhancing effects of septal oxytocin receptors
Guzmán, Y. F., Tronson, N. C., Jovasevic, V., Sato, K., Guedea, A. L., Mizukami, H., Nishimori, K., & Radulovic, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3465 · Cited by 215 · cited 1×
“It is also important to consider emerging evidence that OT is not solely involved in reducing fear and anxiety but can also have the opposite action and can increase fear and anxiety (Bartz et al., 2011; Grillon et al., 2013; Guzman et al., 2013; Lahoud and Maroun, 2013; Toth et al., 2012).”
BackgroundBehavioral effects of neuropeptides in rodent models of depression and anxiety
Rotzinger, S., Lovejoy, D. A., & Tan, L. A. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.015 · Cited by 211
Distributed circuits underlying anxiety
Adhikari, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00112 · Cited by 204
Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats
Slattery, D. A., & Neumann, I. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.038 · Cited by 195
Oxytocin increases anxiety to unpredictable threat
Grillon, C., Krimsky, M., Charney, D. R., Vytal, K., Ernst, M., & Cornwell, B. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.156 · Cited by 192 · cited 1×
“It is also important to consider emerging evidence that OT is not solely involved in reducing fear and anxiety but can also have the opposite action and can increase fear and anxiety (Bartz et al., 2011; Grillon et al., 2013; Guzman et al., 2013; Lahoud and Maroun, 2013; Toth et al., 2012).”
BackgroundFatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex
Kozorovitskiy, Y., Hughes, M., Lee, K., & Gould, E. (2006) · Nature Neuroscience · doi:10.1038/nn1753 · Cited by 158 · cited 1×
“However, receptors for the structurally similar neuropeptide, vasopressin (AVP), are also found in the mPFC (Kozorovitskiy et al., 2006; Smeltzer et al., 2006).”
BackgroundEndogenous oxytocin is involved in short-term olfactory memory in female rats
Engelmann, M., Ebner, K., Wotjak, C. T., & Landgraf, R. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00084-3 · Cited by 156 · cited 2×
“In addition to its well-known role in various social behaviors, (Bale et al., 2001; Bosch and Neumann, 2012; Calcagnoli et al., 2015; Caldwell, 2012; Engelmann et al., 1998; Lim and Young, 2006; Meyer-Lindenberg et al., 2011) the neuropeptide oxytocin (OT) has been”
BackgroundOxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Gould, B. R., & Zingg, H. H. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00283-5 · Cited by 138 · cited 2×
“OTR are located in the mPFC (Duchemin et al., 2017; Gould and Zingg, 2003; Insel and Shapiro, 1992; Liu et al., 2005; Mak et al., 2012; Mitre et al., 2016; Nakajima et al., 2014; Smeltzer et al., 2006) although little is known about subregional differences in OTR density which may be another factor…”
BackgroundRamos, L., Hicks, C., Kevin, R., Caminer, A., Narlawar, R., Kassiou, M., & McGregor, I. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.125 · Cited by 128 · cited 2×
“…OT’s moderate to strong affinity for the V1a subtype of the AVP receptor and there are studies showing that some behavioral effects of OT, particularly social behaviors, involve the V1a receptor (Bowen and McGregor, 2014; Hicks et al., 2012; Mak et al., 2012; Ramos et al., 2013; Sala et al., 2011).”
BackgroundBethlehem, R. A. I., Baron-Cohen, S., van Honk, J., Auyeung, B., & Bos, P. A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00048 · Cited by 120
Ninan, I. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07430.x · Cited by 110
Toth, I., Neumann, I. D., & Slattery, D. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2702-4 · Cited by 107
Sabihi, S., Durosko, N. E., Dong, S. M., & Leuner, B. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.009 · Cited by 106 · cited 9×
“Testing for anxiety-related behavior was done 15 min after the OT or saline infusion which is consistent with other studies examining the behavioral effects of OT (Bale et al., 2001; Lukas et al., 2011; Sabihi et al., 2014b).”
BackgroundMethodResultInfluentialSelf-citationYoung, K. A., Liu, Y., Gobrogge, K. L., Wang, H., & Wang, Z. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4275-13.2014 · Cited by 99
Sobota, R., Mihara, T., Forrest, A., Featherstone, R. E., & Siegel, S. J. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000074 · Cited by 80 · cited 2×
“Thus, reduced neuronal activation of the BLA after OT administration and the accompanying attenuation of anxiety-like behavior is consistent with diminished excitatory drive to BLA neurons and corroborates other work showing reduced amygdala activation following peripheral OT administration (Sobota et al., 2015).”
ResultNeurons in the Amygdala with Response-Selectivity for Anxiety in Two Ethologically Based Tests
Wang, D. V., Wang, F., Liu, J., Zhang, L., Wang, Z., & Lin, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018739 · Cited by 78 · cited 1×
“The BLA is the main target of glutamatergic projections from the PL mPFC (Gabbott et al., 2005; Vertes, 2004) and increased activation of the BLA is associated with heightened anxiety (Hale et al., 2006; Tye et al., 2011; Wang et al., 2011).”
BackgroundOxytocin and vasopressin: Social neuropeptides with complex neuromodulatory functions
Benarroch, E. E. (2013) · Neurology · doi:10.1212/wnl.0b013e31828cfb15 · Cited by 74
Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/−) reeler mice
Liu, W., Pappas, G. D., & Carter, C. S. (2005) · Neurological Research · doi:10.1179/016164105x35602 · Cited by 73 · cited 2×
“OTR are located in the mPFC (Duchemin et al., 2017; Gould and Zingg, 2003; Insel and Shapiro, 1992; Liu et al., 2005; Mak et al., 2012; Mitre et al., 2016; Nakajima et al., 2014; Smeltzer et al., 2006) although little is known about subregional differences in OTR density which may be another factor…”
BackgroundHicks, C., Jorgensen, W., Brown, C., Fardell, J., Koehbach, J., Gruber, C. W., Kassiou, M., Hunt, G. E., & McGregor, I. S. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02311.x · Cited by 73
Oxytocin and vasopressin modulate the social response to threat: a preclinical study
Bowen, M. T., & McGregor, I. S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000388 · Cited by 63 · cited 2×
“…OT’s moderate to strong affinity for the V1a subtype of the AVP receptor and there are studies showing that some behavioral effects of OT, particularly social behaviors, involve the V1a receptor (Bowen and McGregor, 2014; Hicks et al., 2012; Mak et al., 2012; Ramos et al., 2013; Sala et al., 2011).”
BackgroundOxytocin interference in the effects induced by inhalation of 7.5% CO2 in healthy volunteers
de Oliveira, D. C. G., Chagas, M. H. N., Garcia, L. V., Crippa, J. A. S., & Zuardi, A. W. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2237 · Cited by 39
Cited by
Medial prefrontal cortex in neurological diseases
Xu, P., Chen, A., Li, Y., Xing, X., & Lu, H. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00006.2019 · Cited by 341
Oxytocin signaling in the lateral septum prevents social fear during lactation
Menon, R., Grund, T., Zoicas, I., Althammer, F., Fiedler, D., Biermeier, V., Bosch, O. J., Hiraoka, Y., Nishimori, K., Eliava, M., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.02.044 · Cited by 211
Bredewold, R., & Veenema, A. H. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.02.011 · Cited by 144
“The OXT effects on anxiety in rats were restricted to the prelimbic mPFC, required OTR (not V1aR) activation, and were likely mediated via activation of GABAergic interneurons [54].”
BackgroundHelpman, L., Zhu, X., Suarez-Jimenez, B., Lazarov, A., Monk, C., & Neria, Y. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0854-y · Cited by 82
Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects
Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72
Metadata
- Authors
- Sabihi, S., Dong, S. M., Maurer, S. D., Post, C., & Leuner, B.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 125
- Pages
- 1-12
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2635338433
- Cited by
- 81
- References
- 64
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.